Education
About Us
Working with TipRanks
Follow Us
OTIS W BRAWLEY Insider Profile
11 Followers
OTIS W BRAWLEY, Director at PDS Biotechnology, holds ― shares in PDS Biotechnology (Ticker: PDSB), holds 11.25K shares in Incyte (Ticker: INCY), holds 35.64K shares in Lyell Immunopharma (Ticker: LYEL). Most recently, OTIS W BRAWLEY ― shares of PDS Biotechnology on ― for an estimated value of ―.
OTIS W BRAWLEY has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that OTIS W BRAWLEY holds in companies
Most Profitable Insider Trade
The most profitable trade made by OTIS W BRAWLEY
OTIS W BRAWLEY's Trading History
PDS Biotechnology
―
Director
―
―
Incyte
Jun 12, 2025
Director
Uninformative Buy
―
$795.40K
Agilent
Mar 18, 2025
Director
Uninformative Buy
318.82K
$1.28M
Lyell Immunopharma
Apr 02, 2025
Director
Informative Buy
19.96K
$391.68K
List of latest transactions for each holding click on a transaction to see OTIS W BRAWLEY's performance on stock
You May Also Like
OTIS W BRAWLEY insider profile FAQ
What is the percentage of profitable transactions made by OTIS W BRAWLEY?
The percentage of profitable transactions made by OTIS W BRAWLEY is ―.
What is the average return per transaction made by OTIS W BRAWLEY?
The average return per transaction made by OTIS W BRAWLEY is ―.
What stocks does OTIS W BRAWLEY hold?
OTIS W BRAWLEY holds: PDSB, INCY, A, LYEL stocks.
What was OTIS W BRAWLEY’s latest transaction?
OTIS W BRAWLEY latest transaction was an Uninformative Buy of ―.
What was OTIS W BRAWLEY's most profitable transaction?
OTIS W BRAWLEY’s most profitable transaction was an Informative Buy of LYEL stock on April 2, 2025. The return on the trade was -8.90%.
What is OTIS W BRAWLEY's role in PDS Biotechnology?
OTIS W BRAWLEY's role in PDS Biotechnology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.